Literature DB >> 8476254

Malignant melanoma.

J A Sanchez1, W A Robinson.   

Abstract

Malignant melanoma is the most rapidly increasing cancer in Caucasians throughout the world. The increased incidence is due to greater sun exposure arising from changes in clothing habits and life-styles over the past fifty years. Most melanomas arise in preexisting moles in sun-exposed sites and may spread rapidly via the vascular system if not detected and removed early. Treatment of disseminated disease is unsatisfactory, with most patients dying of refractory brain metastases.

Entities:  

Mesh:

Year:  1993        PMID: 8476254     DOI: 10.1146/annurev.me.44.020193.002003

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  4 in total

1.  Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4.

Authors:  Yi Yang; Liang Jin; Juan He; Rui Wang; Yilin Wang; Jia Bai; Youbai Chen; Zhanpeng Luo
Journal:  Mol Cell Biochem       Date:  2022-07-15       Impact factor: 3.842

2.  Tumor-promoting properties of karyopherin β1 in melanoma by stabilizing Ras-GTPase-activating protein SH3 domain-binding protein 1.

Authors:  Fan Yang; Lin Li; Zhenzhen Mu; Pengyue Liu; Ying Wang; Yue Zhang; Xiuping Han
Journal:  Cancer Gene Ther       Date:  2022-07-28       Impact factor: 5.854

3.  Vacations to waterside locations result in nevus development in Colorado children.

Authors:  Kelly J Pettijohn; Nancy L Asdigian; Jenny Aalborg; Joseph G Morelli; Stefan T Mokrohisky; Robert P Dellavalle; Lori A Crane
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

4.  Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.

Authors:  Jie Ren; Jiaqi Yang; Song Na; Yiqian Wang; Linyun Zhang; Jinkui Wang; Jiwei Liu
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.